Saturday, May 26, 2018

Herbalife plunges after Carl Icahn said he is lowering his stake in the company

Carl Icahn's Icahn Enterprises is finally taking some profits on its Herbalife winnings.

On Friday the investor said he is lowering his stake in a securities filing.

"Yesterday IEP tendered its Herbalife shares into the Company's self-tender offer. Of the shares we tendered, at most only 11.4 million could possibly be purchased in the tender, which would still leave us as the Company's largest shareholder with at least 34.3 million shares," Icahn wrote. "For almost six years, we have been one of Herbalife's strongest, most loyal supporters; we stood by the Company through a half-decade long short-selling campaign; and we never sold a share, even after our investment doubled. But, given that our Herbalife investment has become an outsized position, representing approximately 24% exposure to total NAV, it is only prudent for IEP to reduce its exposure."

Shares of Herbalife declined 7 percent in early trading Friday.

show chapters When you're lucky you can't always confuse it with being smart: Carl Icahn When you're lucky you can't always confuse it with being smart: Carl Icahn    2:28 PM ET Mon, 21 May 2018 | 06:34

On Friday Herbalife announced the results of its tender offer. The company said it was "oversubscribed" with 49.7 million shares tendered. It expects to accept 11.4 million shares at a cash purchase price of $52.50 per share or roughly $600 million. Herbalife will fund the stock repurchase from its term loans, credit facilities or cash on hand.

As the largest Herbalife shareholder Icahn repeatedly battled Pershing Square's Bill Ackman over his bearish stance on the nutritional supplement maker.

In March Icahn took a victory lap on his profitable Herbalife investment, telling CNBC he had "a billion" dollar profit in the stock.

The investor seemed to reference Ackman's exit of his losing bearish bet as a reason why he's reducing his stake.

"We believe Herbalife's business is stable, the short-sellers have largely exited, and the Company is well-positioned for the future," Icahn said in the Friday filing.

Herbalife did not immediately respond to a request for comment.

Friday, May 25, 2018

Alliance Holdings GP (AHGP) Receiving Somewhat Positive Media Coverage, Accern Reports

Media coverage about Alliance Holdings GP (NASDAQ:AHGP) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alliance Holdings GP earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news stories about the energy company an impact score of 46.7653698942919 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

AHGP has been the topic of a number of research analyst reports. BidaskClub raised shares of Alliance Holdings GP from a “sell” rating to a “hold” rating in a report on Thursday, January 25th. ValuEngine cut shares of Alliance Holdings GP from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. TheStreet cut shares of Alliance Holdings GP from a “b-” rating to a “c+” rating in a report on Wednesday, February 28th. Finally, Zacks Investment Research cut shares of Alliance Holdings GP from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. The company currently has an average rating of “Hold” and an average price target of $31.33.

Get Alliance Holdings GP alerts:

Shares of AHGP stock opened at $27.25 on Thursday. The company has a current ratio of 1.15, a quick ratio of 0.82 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $1.59 billion, a PE ratio of 8.52 and a beta of 0.58. Alliance Holdings GP has a 52-week low of $22.56 and a 52-week high of $31.79.

Alliance Holdings GP (NASDAQ:AHGP) last announced its quarterly earnings results on Monday, April 30th. The energy company reported $1.73 EPS for the quarter, beating the Zacks’ consensus estimate of $0.96 by $0.77. Alliance Holdings GP had a net margin of 13.10% and a return on equity of 20.35%. The business had revenue of $457.04 million for the quarter.

The business also recently declared a quarterly dividend, which was paid on Friday, May 18th. Investors of record on Friday, May 11th were paid a $0.748 dividend. The ex-dividend date was Thursday, May 10th. This represents a $2.99 dividend on an annualized basis and a yield of 10.98%. This is a positive change from Alliance Holdings GP’s previous quarterly dividend of $0.74. Alliance Holdings GP’s dividend payout ratio is 93.44%.

About Alliance Holdings GP

Alliance Holdings GP, L.P., together with its subsidiaries, produces and markets coal primarily to utilities and industrial users in the United States. It operates through Illinois Basin and Appalachia segments. The company operates eight underground mining complexes in Illinois, Indiana, Kentucky, Maryland, and West Virginia.

Insider Buying and Selling by Quarter for Alliance Holdings GP (NASDAQ:AHGP)

Thursday, May 24, 2018

Top Canadian Stocks To Invest In Right Now

tags:BRD,PMT,CNR,NG,

The Bank of Canada kept borrowing costs on hold Wednesday and indicated it’s no rush to pursue aggressive interest rate hikes amid growing global trade tensions and softer housing data.

The statement, which left the benchmark rate at 1.25 percent, repeated dovish language about moving cautiously in an economy that will require continued stimulus. The broader trade comment was new, though policy makers made no explicit mention of U.S. President Donald Trump’s threats to impose tariffs on steel and aluminum.

While global growth is “solid and broad-based,” recent developments in trade policy have become “an important and growing source of uncertainty” for the Canadian economic outlook, the central bank said.

Investors have pared bets on rate hikes after a run of soft economic data, turmoil in global equity markets and growing geopolitical concerns. That may increase Bank of Canada Governor Stephen Poloz’s caution about any decision to tighten monetary policy further. While the Bank of Canada has been highlighting risks to the North American Free Trade Agreement for months, the latest language suggests those concerns have evolved.

Top Canadian Stocks To Invest In Right Now: Apollo Gold Corporation(BRD)

Advisors' Opinion:
  • [By Ethan Ryder]

    Bread (CURRENCY:BRD) traded 10.1% lower against the U.S. dollar during the 24-hour period ending at 15:00 PM ET on May 6th. Bread has a market cap of $73.13 million and approximately $1.09 million worth of Bread was traded on exchanges in the last 24 hours. One Bread token can currently be purchased for about $0.82 or 0.00008683 BTC on popular exchanges including OKEx, Binance and Cobinhood. In the last seven days, Bread has traded 3.3% higher against the U.S. dollar.

Top Canadian Stocks To Invest In Right Now: PennyMac Mortgage Investment Trust(PMT)

Advisors' Opinion:
  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) shares reached a new 52-week high and low on Monday . The company traded as low as $18.60 and last traded at $18.62, with a volume of 19306 shares changing hands. The stock had previously closed at $18.50.

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) – Equities researchers at Wedbush lifted their Q1 2019 earnings per share estimates for shares of Pennymac Mortgage Investment in a research note issued to investors on Thursday, May 10th. Wedbush analyst J. Weaver now anticipates that the real estate investment trust will post earnings per share of $0.36 for the quarter, up from their previous estimate of $0.34. Wedbush also issued estimates for Pennymac Mortgage Investment’s Q2 2019 earnings at $0.43 EPS, Q3 2019 earnings at $0.43 EPS, Q4 2019 earnings at $0.52 EPS and FY2019 earnings at $1.74 EPS.

Top Canadian Stocks To Invest In Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:
  • [By Shane Hupp]

    Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

Top Canadian Stocks To Invest In Right Now: Natural Gas(NG)

Advisors' Opinion:
  • [By Money Morning News Team]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last six months, the volume of short bets on the stock declined 32.75%, from 19.05 million shares to 12.81 million.

  • [By Shane Hupp]

    JPMorgan Chase set a GBX 870 ($11.80) target price on National Grid (LON:NG) in a research note released on Monday. The brokerage currently has a buy rating on the stock.

  • [By Money Morning Staff Reports]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400.

Tuesday, May 22, 2018

Amazon's Advertising Business: An Emerging Giant

On April 23, prior to Amazon's (AMZN) Q1 results, we wrote an article urging investors to pay attention to Amazon's emerging advertising business, which in my view has been a hidden gem. Sure enough, Amazon's advertising business did not disappoint in Q1 and received increasing attention from analysts. Furthermore, since publishing our article, Amazon's advertising business gained increasing press attention. In this article, armed with new information, I will address some of our readers' questions and update our thinking on the future of this business.

Amazon's Q1 Results

Source: ZenAnalyst.com

As mentioned in our previous article, I believe that the majority of Amazon's "Other" revenue consists of its advertising revenue and should be used a proxy for that business. A reader asked how I know this, and the answer at the time was simply "I have been following Amazon closely and pieced together various information and used a few assumptions." For those who are unsatisfied with this answer, Amazon's CFO helped me out during this quarter's earnings call by confirming my estimate:

I would say advertising continues to be a bright spot both from a product standpoint and also financially. It continued to be a strong contributor to profitability in Q1. It's now a multibillion-dollar program. You can see the - in our supplemental revenue disclosure, it's in other revenue, and it's the majority of the other revenue in that line item.

So, with that out of the way, and to avoid confusion and simplify discussion, we will henceforth refer to "Other" as "advertising".

There is no little doubt that Amazon's advertising business accelerated strongly in Q1, as advertising revenue grew a record 139% y/y. Note that an accounting change contributed $560M to the "Other" line. Excluding this change, "Other" would have grown 73% y/y, which is of course still a massive number.

Source: ZenAnalyst.com

Advertising as a % of Amazon's total business also hit a record 4.0%, which is also the largest sequential increase ever. If the market has not been paying attention before, they better be paying attention now! I'm looking at you, Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) and Facebook (FB) bulls.

Amazon's CFO provided additional color on its advertising business on the earnings call. Below are a few select quotes I believe would aid investors' understanding of Amazon's advertising strategy:

So our philosophy there again is we're continuing to focus on finding valuable ways to make our advertising opportunities better for customers, showing them new products that they may not have seen otherwise and also for emerging and established brands, helping them to reach customers. I think the advertisers generally are all shapes and sizes, and their common theme is they all want to reach our customers generally to drive brand awareness, discovery and eventually purchase.

...

On advertising, so let's step back a bit. It's now a multibillion-dollar program and growing very quickly. Our main goal here is to help customers discover new brands and products. So we show the sponsored products, we're trying to show people things they had maybe wouldn't have seen otherwise in their normal search results. So we're looking for a good balance here, as we said.

We want customers to get the benefit of the new brand and product discovery, and then we want to let sellers for both emerging and established brands, reach those customers. Those advertisers are of all shapes and sizes with the main goal of, again, trying to reach our customers whether it's to drive brand awareness, discovery or hopefully purchase. So, we take the responsibility for that very seriously and are always balancing helpfulness of the advertising and try not to make it disruptive. But you're right, there are always pressures in that. We will come down on the side of the customer. On your question on video advertising, yes, there may be opportunities over time to have more advertising in our Video, but we choose not to do that right now

My take of the above quotes: I am impressed by their consistency of always putting customers first and excited by the prospect of other advertising opportunities such as video and other unstated opportunities such as music, package, and anywhere else in their vast ecosystem that touch customers. Since Amazon's ad load is currently very light, the potential is mind-boggling.

Other Developments

After Amazon reported earnings on April 26th, its advertising business gained massive media coverage, receiving coverage from CNBC, Digiday, Adage, Reuters, among others.

On May 4th, Merkle reported that Amazon stopped buying product listing ads from Google. Bloomberg confirmed this report on May 10th, which is how most market participants learned of this intriguing development.

Source: Merkle

This is a bold move by Amazon and a strong signal to the market. First, it confirms our thesis that the tech giants are increasing at war with each other as they seek growth. The number of confrontations between Amazon and Google has certainly increased in recent years, and it is an issue we already addressed in a recent article.

The second signal is that Amazon is sufficiently confident in itself to bypass Google all together. And why wouldn't they be confident? According to Survata, in 2017, 49% of US consumers began their online product searches on Amazon vs. 36% of consumers beginning their product search on all search engines, including Google.

Shortly after this news, on May 14th, Bloomberg reported that Amazon is testing a new display ad offering that threatens multibillion-dollar revenue streams at Google and firms like Criteo S.A. (CRTO). According to Bloomberg, "The new tool lets these sellers bid on ads that will appear on other websites and apps, giving them much wider reach."

This is a very interesting development, although one that wouldn't surprise close Amazon observers. Amazon already offers ads that appear on other websites through its Amazon Associates program, the largest affiliated marketing program in the world. To demonstrate how this type of ad works in real life, visit my blog, ZenAnalyst.com, where I set up an "You May Like These" ad for demonstration purposes. You'll notice that the displayed items are the ones that you recently browsed for on Amazon.com. If you click on that ad and make any purchase, the website host (me) earns a small commission.

Although I do not have enough information to make an exact conclusion, this new tool appears to be Amazon's attempt to shift that advertising costs from Amazon to brands.

Concluding Thoughts

The rapid emergence of Amazon's high-margin advertising business is nothing short of astonishing and reminds me of the emergence of AWS, Kindle, and Alexa, which all seemed to have taken the world by surprise. I believe there is no reason why Amazon's advertising business could not grow to the scale enjoyed by Facebook and Google.

To support this view, I point to the accelerating growth of this business, Amazon's bold moves as highlighted in this article, the increasing concern over Facebook and Google's current duopoly on digital advertising, and Amazon's various advantages over advertising platforms. These advantages include Amazon's 100 million prime members, the fact that significantly more consumers begin their online product search on Amazon than on all search engines (as previously discussed), and Amazon's physical engagement with consumers through its Whole Foods stores, Echo, and packages delivered to customers' homes.

I'm very bullish on Amazon's advertising business and think it should be getting much more attention than it has. What do you think? Let's discuss below! Thank you for reading, and please follow me for future articles.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Sunday, May 20, 2018

Heska: Pets Are People Too

On Tuesday, Heska (HSKA) hosted its first-ever investor day, during which the management team unveiled significant product and geographic expansion plans (as part of its "Second Act") and provided financial guidance through 2022. Though management's guidance is dependent on the success of the company's new product launches (CEO Kevin Wilson indicated that almost half of the projected growth was derived from new product/geographic expansions), it indicates around a 20% upside from where Heska trades today at $102 per share. The guidance is bullish, but Heska is well-positioned to execute, and the management team's interests appear well-aligned with shareholders'. There are some risks to look out for along the way as the whole space touts high multiples, but the probability of success for Heska looks high.

Growth Plans

During the investor day, management announced both new product and geographic expansions. Both expansion opportunities are aiming to penetrate large markets, and if successful, will be very significant for Heska (given the company's smaller size).

Product Expansions:

Urine sediment and chemistry analyzer - Q1'19. There was previously quite a bit of speculation that Heska would enter this market, given previous remarks by the management team and the size of the market, and it looks like that speculation was correct. Pet urinalysis is an over $100M market (with around 5 million annual tests) and is likely to continue to grow. Urinalysis is especially important for older pets and is recommended as a once-per-year test. Element F - Q4'19: This is the product that CEO Kevin Wilson was the most excited about. The Element F will mark Heska's entrance into the fecal test space. This is a huge market with over 30 million tests per year (in-clinic, another 10-15M are sent to reference labs) at an average cost of around $18 per test. Currently, these tests are completed manually in a time-consuming process called fecal flotation (which is the gold standard of the industry). Heska believes it can automate this entire process with the Element F. Element I - Q2'19: The Element I is a high sensitivity immunodiagnostics multiplex analyzer. This is another $100M+ market and is a required annual test for dogs and cats. Cloud Data and AI expansion - Q4'18: Heska will be expanding its cloud data and AI capabilities to learn from and leverage the data it collects from its instruments. The company's platform will pull data from imaging, point-of-care lab testing, urinalysis, and fecal testing. Geographic Expansion Opportunities

Heska also announced its early-stage international expansion plans. The company's current international point-of-care market share is effectively 0%, so there's definitely a lot of room to grow. The two markets management presented an interest in are Australia/New Zealand (Q3'18) and Europe (Q1'19). The Australian market looks attractive for Heska for a couple reasons. First, Australia has more pets per capita than the United States. Second, Heska already has some established logistics channels along with a small install base of instruments in the field that it can leverage. For European expansion, Heska is looking to find a large international partner to enter the market with but will still enter the market if it doesn't find one.

Competitively, Idexx (IDXX) doesn't have the same brand name internationally that it does it the U.S., which should help Heska out in its attempts to gain market share, but as I'll get into a little later, Heska may face some increased competitive pressure from the combined Zoetis (ZTS)-Abaxis (ABAX) entity (assuming the deal goes through). Heska's model is also cheaper than its main competitors and may be more attractive internationally if they are able to successfully enter these proposed markets.

Management Case Valuation

In the investor presentation, management provided guidance on revenue and gross/operating margins for 2020 and 2022.

(Source: 5/15/2018 investor presentation)

When asked by an analyst where most of this growth would come from, CEO Kevin Wilson mentioned that it was split pretty evenly between organic growth and new products/geographies. While this dependence on new product launch successes is more risky than Heska's already established business, the company has a strong track record with 50% of current revenue growth coming from products that have been developed since 2013.

Heska also provided a detailed outlook on key operating costs for 2018 which I included in my model.

(Source: My own chart, data from SEC filings, and the 5/15 investor presentation)

Key Assumptions:

25x EV/EBITDA exit multiple. Heska currently trades around 34x TTM EBITDA, which is less than its peers' median of around 35.3x.

(Source: My own chart, data from GuruFocus and company SEC filings)

Notably, veterinary giant Zoetis just announced an acquisition of Abaxis for around 39x TTM EBITDA. This boost is also the driver of the increase in the relative valuation output to $109. It's clear that the multiples in the space are high across board, and a 25x exit multiple seems like a conservative discount to today's valuations (especially when we consider Heska's future margin expansion potential). WACC of 8.5%. Adjusted up from a CAPM calculation for a size premium. Growth in operating margins from the maturity and growth in the Rental Reset program, which management revealed details about at the investor day. Some key details were: 4% annual price increases of consumables, estimated 5% increase in pet visits per year at the veterinarian practice level with 15% of those visits needing diagnostics (equating to 75 bps of annual growth) and plans to grow market share and keep renewal rates high with the launches of new products and instruments. Gross and operating margins should begin rapidly expanding in 2019 as Heska's Reset contracts grow and mature. Management guidance turns out to be accurate. Management definitely gave bullish forecasts at the investor day, but I think these are pretty justifiable considering the economics of the Rental Reset program, Heska's competitive positioning in the industry and the sizes of the new markets Heska is entering. Also, the management team has a pretty sizeable stake in the company at 8.95%, with CEO Kevin Wilson owning around 5.5% of the total shares outstanding, which is a promising sign. The stock also has pretty low short-interest (at 3.8% of float), with the only interest really coming from short-ETF/short index-type funds.

(Source: Bloomberg)

M&A Activity

M&A activity in the pet healthcare space has been heating up. In the last few weeks, we have seen two major acquisitions, first, with Heska's partner Henry Schein (HSIC) announcing that they will spin-off their animal health-care business and merge it with Vets First Choice, and second, with Zoetis' $2B bid for Heska's direct competitor Abaxis.

The implications of these moves are multi-faceted for Heska. On one hand, the Henry Schein deal looks like a positive move that may provide Heska with a potential international partnership opportunity. Heska announced that they are looking to expand into Europe through a joint venture, and a partnership with Vets First Choice seems like it would make a lot of sense given Heska's existing relationship and exclusive distribution agreements with Henry Schein.

Looking at the Zoetis-Abaxis deal, the price paid looks positive for Heska with takeout multiples of around 7x TTM sales and 39x TTM EBITDA (after backing Abaxis' cash out of the enterprise value) compared to Heska's current multiples of around 5.8x TTM sales and 34x TTM EBITDA. These multiples assert Zoetis' confidence about the continued growth of the diagnostics space. Zoetis cited international adoption of point-of-care testing/equipment, increasing standards of veterinary care, and the convenience of in-clinic testing as some of the key drivers of growth. Aside from the price of the deal though, this doesn't look too positive for Heska from a competitive standpoint. Zoetis has a global presence with expansive international networks and will most likely ramp-up Abaxis' global growth plans (which are already ahead of Heska's). Zoetis also supplies Heska with its Element COAG product, which is a key product for Heska that is often placed in the field as part of the company's Reset program. The instrument is supplied with a contractual agreement that has been successful for both companies, so it doesn't look very likely that Heska will lose the rights to the instrument, though this very well could affect potential future partnerships between the two companies.

Conclusion

Heska has an attractive business model and a strong competitive position within the veterinary diagnostics space, and given the recent run-up in the stock price, it looks like investors are beginning to realize that. Heska has increased its market share from 3% to 10% in the last five years and looks poised to continue its growth streak. Management's projections at the investor day imply around a 20% upside to today's share price, though the projections seem bullish and it may be wise to slightly discount the value of Heska's planned international expansions given Zoetis' entrance. That being said, the management team at Heska is very competent and has a significant stake in the game. The industry is heating up and multiples are riding high, however, Heska trades right around its continuously increasing intrinsic value. Much of the discount to today's intrinsic value has been eroded by the recent share price appreciation, but Heska remains a solid hold.

Disclosure: I am/we are long HSKA.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.